Drug-Drug Interaction Study of Glucokinase Activator HMS5552 and Metformin in T2DM
Status:
Completed
Trial end date:
2015-10-01
Target enrollment:
Participant gender:
Summary
This is a Phase 1, open-label, sequential, multiple-dose, drug-drug interaction study of GK
activator HMS5552 and metformin in patients with type 2 diabetes mellitus (T2DM).